Detection and clinic implication of circulating tumor cell in patients with lung cancer.
- Author:
Xin-lin MU
1
;
Long-yun LI
Author Information
1. Department of Respiratory Disease, PUMC Hospital, CAMS and PUMC, Beijing 100730, China.
- Publication Type:Journal Article
- MeSH:
Biomarkers, Tumor;
blood;
Carcinoma, Squamous Cell;
blood;
pathology;
Flow Cytometry;
Humans;
Lung Neoplasms;
blood;
pathology;
Neoplastic Cells, Circulating;
pathology;
Reverse Transcriptase Polymerase Chain Reaction;
Sensitivity and Specificity
- From:
Acta Academiae Medicinae Sinicae
2004;26(3):313-318
- CountryChina
- Language:Chinese
-
Abstract:
Micrometastasis may occur in the early stage of lung cancer and dissemination of lung cancer cells into blood circulation is pivotal for metastasis. Many approaches, such as polymerase chain reaction, magnetic activated cell sorting, flow cytometery, and rare event imaging system, have been developed rapidly. The detection of circulating tumor cells may renew the clinical stage and treatment of lung cancer.
